Triglyceride metabolism

Pathway network for the Triglyceride metabolism SuperPath

Sources:
  • Reactome

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Triglyceride metabolism SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Ellis-van creveld syndromeEnrichmentPRKACA, PRKACB3.97
2Majeed syndromeEnrichmentLPIN22.99
3Autosomal dominant charcot-marie-tooth disease type 2 due to dgat2 mutationEnrichmentDGAT22.99
4Lipodystrophy, congenital generalized, type 3EnrichmentCAV12.75
5Pulmonary hypertension, primary, 3EnrichmentCAV12.75
6Cardioacrofacial dysplasia 2EnrichmentPRKACB2.75
7Lipodystrophy, familial partial, type 7EnrichmentCAV12.75
8Pigmented nodular adrenocortical disease, primary, 4EnrichmentPRKACA2.75
9Cardioacrofacial dysplasia 1EnrichmentPRKACA2.75
10Noonan syndrome-like disorder with loose anagen hair 2EnrichmentPPP1CB2.75
11Glycerol kinase deficiencyEnrichmentGK2.69
12Myoglobinuria, acute recurrent, autosomal recessiveEnrichmentLPIN12.51
13Chanarin-dorfman syndromeEnrichmentABHD52.45
14Bleeding disorder, platelet-type, 19EnrichmentPRKACG2.45
15Noonan syndrome-like disorder with loose anagen hairEnrichmentPPP1CB2.45
16Fibrolamellar carcinomaEnrichmentPRKACA2.45
17Diarrhea 7, protein-losing enteropathy typeEnrichmentDGAT12.38
18Hereditary recurrent myoglobinuriaEnrichmentLPIN12.38
19Congenital diarrhea 7 with exudative enteropathyEnrichmentDGAT12.29
20Lipodystrophy, familial partial, type 6EnrichmentLIPE2.28
21Lipodystrophy, familial partial, type 4EnrichmentPLIN12.28
22DiarrheaEnrichmentDGAT12.21
23Diffuse cutaneous systemic sclerosisEnrichmentCAV12.05
24Limited sclerodermaEnrichmentCAV11.98
25Heritable pulmonary arterial hypertensionEnrichmentCAV11.71
26Autoinflammatory diseaseEnrichmentLPIN21.61
27Dandy-walker syndromeEnrichmentPPP1CB1.53
28Male infertilityEnrichmentGPAT21.46
29Noonan syndrome 1EnrichmentPPP1CB1.40
30RasopathyEnrichmentPPP1CB1.35
31Type 2 diabetes mellitusEnrichmentGPD21.14

Loading...
Loading...
Loading...